INTRODUCTION
The excretion of erythrocytes in urine is physiological and up to 75% of healthy men have erythrocytes in their urine 1 . This physiological presence of erythrocytes is not fully understood, though exercise, fever, trauma and coitus are known to transiently induce hematuria.
The recommendation for asymptomatic microscopic hematuria has always been a comprehensive urological examination, because it could be due to urological malignancy. In recent years, it has become clear that the evidence for such an approach is weak [2] [3] [4] . Still many national guidelines 5, 6 recommend urological examination for patients with asymptomatic hematuria, some even suggest a 36-month follow-up if an initial urological examination is negative 5 .
Detection of erythrocytes on dipstick is based on oxidation of at test-strip reagent, and hematuria as well as myoglobinuria, urinary tract infection, alkaline urine and highly concentrated urine can cause this reaction. The specificity for dipstick hematuria ranges from 56-100% 7 . Despite this, patients are often referred to extensive urological examination due to asymptomatic microscopic hematuria found on a dipstick, without a prior microscopic verification 8 . In countries which still recommend urological examination for asymptomatic microscopic hematuria, this could result in unnecessary radiation, discomfort, cost and anxiety for patients with no or only physiological amount of erythrocytes in the urine.
The aim of the study was to identify how many patients, previously examined for asymptomatic microscopic hematuria, still had microscopically hematuria or physiological hematuria. Most patients are referred to urological examination for asymptomatic microscopic hematuria based on dipstick hematuria, without verifying it by microscope. The hypothesis was that dipstick is insufficient to differentiate between physiological hematuria and asymptomatic microscopic hematuria.
METHOD
This is a follow-up study of patients who had been referred with asymptomatic microscopic hematuria to the Department of Urology, Aalborg University Hospital, North Denmark Regional Hospital during the years 2012 -2014. The participants were identified via International Classification of Diseases. A search was made in The Danish National Patient Registry, for patients with the diagnosis microscopic hematuria, DR319B. Inclusion were based on patient charts. The urological examination, the referral, the description of the cystoscopy and CT-urography, earlier admissions and out-patients contacts were reviewed. The inclusion criteria were 1) urological examination with CT-urography and cystoscopy, without abnormal findings 2) no symptoms 3) creatinine within reference interval 4) absence of leukocytes, nitrite or protein on the dipstick. The patients were asked to participate in a letter. The participants were instructed in voiding a fresh urine sample using the correct technique. The urine was examined within 10 minutes. All samples were examined by the same laboratory technician with 25 years of experience in microscopy. Two different multi urine dipsticks (testing for erythrocytes, hemolysis, protein, glucose, pH and nitrite) were used, produced by either Siemens or Combur. Ten ml of urine were within 10 minutes of collection centrifuged (1500 rpm for 3 minutes). One drop of the resulting sediment was colored with Sternheim And Malbins color-fluid and examined using 400x magnification. A minimum of 10 high-power fields were used. The definition of microscopic hematuria varies but this study used the most common definition; ≥3 erythrocytes per high-power field 5, 6 . Hematuria on a dipstick was defined as ≥+1 (~25 erythrocytes/µL) for Siemens and ≥+2 (῀25 erythrocytes/µL) for Combur, according to the product information. The use of anticoagulants was noticed.
The results of the testing from the two producers were comparable and because Siemens is the most used dipstick among general practitioners in North Jutland, Denmark, the dipstick from Siemens was chosen to be point of reference. Sensitivity was compared using Chi-squared test with a prespecified, two-sided significance level of 0.05. Statistical analysis was preformed using SPSS ver 23.
RESULTS
Six-hundred potential participants were identified via The Danish National Patient Registry, International Classification of Diseases, and after reviewing the patients' medical records, 406 were excluded based on the presence of urogenital symptoms, gross hematuria or abnormal findings (CT-urography or cystoscopy). One-hundred-ninety-four were invited of which 79 agreed to participate, resulting in a response rate of 41%. Six participants had cystitis, hemospermia or proteinuria and therefore excluded. Thus, a total of 73 participants were included in the study, 36 men and 37 women with a mean age of 58 and 60 years, respectively. Fifty-two of 73 (71%) had hematuria on dipstick. Thirty-six of the 52 (69 %) were confirmed by microscopic examination while 16 out of the 52 (31%) had to few or no erythrocytes to classify it as hematuria. Only 1 of the 16 had no erythrocytes at all. Four participants had trace on urine dipstick and a positive microscopy. The results are outlined in Table 1 We found that dipstick urine analysis sensitivity was 90% and specificity 51.5%.
There is a significant reciprocal relation between the degree of hematuria and the risk of dipstick hematuria that cannot be confirmed by microscopy [p=0.001]. Sixty-one % of participants with +1 erythrocytes on dipstick had to few or no erythrocytes to classify it as microscopic hematuria. All participant with +3 erythrocytes on dipstick had microscopic hematuria when microscopically examined.
In this study, no associations between hematuria and the use of anticoagulants, gender, age or hemolysis on the dipstick were found (data not shown).
DISCUSSION
Hematuria is physiological, and Sanders et al 1 reported that 74 % of 725 healthy males had erythrocytes in the urine when microscopically examined. The prevalence of microscopic hematuria (more erythrocytes than physiological expected), is 2-13% 9 in the general population. Our study in patients diagnosed asymptomatic microscopic hematuria with negative evaluation, found that 71% (52) of the participants still had dipstick hematuria upon reexamination in line with a previous follow-up study of 191 patients with unexplained microscopic hematuria 10 .
Multi-dipstick is still frequently used and dipstick hematuria is often an incidental finding. In this study, a substantial number of patients with dipstick hematuria had physiological hematuria and not microscopic hematuria. We found that 16 out of 52 (31%) with dipstick hematuria had to few or no erythrocytes to classify it as hematuria when microscopically examined. Of participants with +1 erythrocytes on dipstick, the number was even higher (61%). A similar study 11 found that 21% of their healthy participants had positive dipstick but to few or no erythrocytes to classify it as hematuria, while another study 8 , with lower cutoff-values for hematuria, found this figure to be 15%.
The numbers above suggest that a considerable part of the participants in this study at the time of referral for urological examination had physiological hematuria and not microscopic hematuria, which make the examinations preformed unnecessary. Thus, unnecessary radiation, discomfort, cost and anxiety for patients might have been avoided. This would count for the 16 participants with physiological hematuria, but also the 21 participants with no hematuria at the time of reexamination (ref, this study).
Guidelines recommend microscopically confirmation of dipstick hematuria before referral for urological examination 12 . None-the less a study 13 in 2010 found that only 41% of patients referred with the diagnosis of asymptomatic microscopic hematuria had microscopic urine analysis performed before referral. Furthermore, only 24 % of the referred patients had ≥3 erythrocytes/high power field.
The specificity of hematuria is known to be low. A systematic review 7 from 2006 identified 18 studies dealing with the specificity of dipstick hematuria which varied between 56-100%. The studies were mainly small cohorts with a lack of clinical data on the patients. The wide variation in reported specificity might be explained by the considerable disagreement on the definition of hematuria and method of microscopy. See Table2.
This study found a specificity of 51.5%, which is lower than reported previously (ref, systematic review). The differences between the results in this study compared with the abovementioned studies are partly caused by selection. The cohort in this study was highly selected, to ensure that it represented a group of healthy patients with verified asymptomatic microscopic hematuria. The inclusion criteria in our study was a thorough examination within 2 years with no abnormal findings and no urogenital symptoms. Other studies 8, [14] [15] [16] [17] included participant regardless of medical history, urological examinations and symptoms.
It is of importance that studies regarding asymptomatic microscopic hematuria verify dipstick hematuria microscopically before enrolling patients. If not, there is a risk of including a considerable number of patients with physiological hematuria. This would mask a potential connection between microscopic hematuria and pathology. However, such a connection is controversial. Whereas gross hematuria needs further extensive examinations to exclude or confirm serious pathology, the importance of a thorough evaluation is uncertain when it comes to asymptomatic microscopic hematuria. During the past, it has been discussed whether asymptomatic microscopic hematuria can be a sign of underlying pathology. In recent years, it has become clear that the evidence for this is weak 2, 3 . The most recent study 4 found that the malignancy rate for patients referred with asymptomatic microscopic hematuria was 1,5 %, and the cancers were all detected in patients aged > 60 recommend examination of asymptomatic microscopic hematuria, some even recommend 36-month follow-up for patients with negative evaluation. Especially the latter is controversially. A recent follow-up study of patients with asymptomatic microscopic hematuria with negative evaluation showed that there was no significant differences in incidence of malignancy between participant with asymptomatic microscopic hematuria and no hematuria 19 .
One of the first countries to omit the urological examination of patients with asymptomatic microscopic hematuria was Sweden 3 in 2003.
Testing for microscopic hematuria should be targeted, based on relevant clinical or biochemical information. To avoid unnecessary "noise" for clinicians and to protect the patients against unwarranted referrals and pathologization erythrocytes should be removed from the multi-dipsticks and instead be produced as a single stick. A dipstick negative for hematuria can furthermore provide the false security of no pathology. Urogenital malignancy has an intermittent and variated bleeding pattern 19 . This is the reason that all reported cases of gross hematuria, should be referred even if their dipstick is negative for erythrocytes. A negative dipstick neither shall nor can be a deciding factor when considering referring a patient for further urogenital evaluation. It should be based on reports of gross hematuria and other relevant symptoms. The risk is that clinicians overlook underlying pathology because dipstick hematuria can trigger the clinicians to explore in the patients' urogenital symptoms, which otherwise would have been missed.
CONCLUSION
Seventy-one percent of patients previously referred for asymptomatic microscopic hematuria and without pathological findings at urological examination still had persisting dipstick hematuria. Only 69 % could be verified microscopically. The study suggest that dipstick hematuria should be verified by microscope before referral for urological examination in countries which still recommend examination for asymptomatic microscopic hematuria.
